Real-time enrollment status for this tardive dyskinesia clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:09 PM UTC
| NCT Number | NCT07105111 |
| Recruiting Status | Recruiting |
| Condition | Tardive Dyskinesia |
| Phase | PHASE4 |
| Target Enrollment | 50 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Neurocrine Biosciences |
| Last Updated on CT.gov | June 16, 2026 (Jun 16, 2026) |
As of July 17, 2026: Clinical trial NCT07105111 is currently recruiting participants. This phase4 study for tardive dyskinesia is actively seeking new participants at 22 locations across the United States. The study is sponsored by Neurocrine Biosciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07105111 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07105111 was last updated Jun 16, 2026 (June 16, 2026). HelloStudys verifies this status automatically.